
1. rev iberoam micol. 2012 jul-sep;29(3):115-9. doi: 10.1016/j.riam.2011.09.001.
epub 2011 oct 25.

[relevant aspects hcp100 molecular marker histoplasma capsulatum and
its potential therapeutic use histoplasmosis].

[article spanish]

gonzález-gonzález ae(1), taylor ml, curiel-quesada e.

author information: 
(1)departamento de microbiología parasitología, facultad de medicina,
universidad nacional autónoma de méxico, méxico df, méxico. skapunking
9@yahoo.com.mx

background: fungal pathogens developed strategies, involving genes
expression favors persistence multiplication host. the
absence molecules encoded genes could interfere growth and
death fungi. past, coactivator protein coding gene (hcp100) 
the fungus histoplasma capsulatum reported, overexpressed 1h
of contact fungal yeast-cells murine macrophages. product this
gene, protein 100 kda (hcp100) h. capsulatum, probably regulatory
protein involved processes required fungal adaptation survival
in intracellular hostile conditions macrophages. 210-bp fragment 
the hcp100 marker proved excellent tool h. capsulatum molecular 
detection clinical samples. potential use gene therapeutic
target plasmodium falciparum explored inhibition both,
the gene protein p100 parasite, blocking growth.
methods: based mentioned antecedents, believe hcp100 has
an important role development maintenance h. capsulatum yeast
cells within macrophages.
results conclusions: study probable function hcp100 the
yeast-phase fungal pathogen relevant understand activity to
propose therapeutic target histoplasmosis treatment.

copyright © 2011 revista iberoamericana de micología. published elsevier
espana. rights reserved.

doi: 10.1016/j.riam.2011.09.001 
pmid: 22037114  [indexed medline]

